Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19.
Magdalene JosephYin WuRichard DannebaumFlorian RubeltIva ZlatarevaAnna LorencZhipei Gracie DuDaniel DaviesFernanda Kyle-CezarAbhishek DasSarah GeeJeffrey SeowCarl GrahamDilduz TelmanClara BermejoHai LinHosseinali AsgharianAdam G LaingIrene Del Molino Del BarrioLeticia MoninMiguel Muñoz-RuizDuncan R McKenzieThomas S HaydayIsaac Francos-QuijornaShraddha KamdarRichard DavisVasiliki SofraFlorencia CanoEfstathios TheodoridisLauren MartinezBlair MerrickKaren BisnauthsingKate BrooksJonathan EdgeworthJohn CasonChristine MantKatie J DooresPierre VantouroutKhai LuongJan BerkaAdrian C HaydayPublished in: Proceedings of the National Academy of Sciences of the United States of America (2022)
Whereas pathogen-specific T and B cells are a primary focus of interest during infectious disease, we have used COVID-19 to ask whether their emergence comes at a cost of broader B cell and T cell repertoire disruption. We applied a genomic DNA-based approach to concurrently study the immunoglobulin-heavy (IGH) and T cell receptor (TCR) β and δ chain loci of 95 individuals. Our approach detected anticipated repertoire focusing for the IGH repertoire, including expansions of clusters of related sequences temporally aligned with SARS-CoV-2-specific seroconversion, and enrichment of some shared SARS-CoV-2-associated sequences. No significant age-related or disease severity-related deficiencies were noted for the IGH repertoire. By contrast, whereas focusing occurred at the TCRβ and TCRδ loci, including some TCRβ sequence-sharing, disruptive repertoire narrowing was almost entirely limited to many patients aged older than 50 y. By temporarily reducing T cell diversity and by risking expansions of nonbeneficial T cells, these traits may constitute an age-related risk factor for COVID-19, including a vulnerability to new variants for which T cells may provide key protection.
Keyphrases
- sars cov
- high throughput sequencing
- coronavirus disease
- regulatory t cells
- respiratory syndrome coronavirus
- genome wide
- end stage renal disease
- copy number
- infectious diseases
- ejection fraction
- newly diagnosed
- physical activity
- magnetic resonance imaging
- healthcare
- climate change
- chronic kidney disease
- computed tomography
- circulating tumor
- genome wide association study
- gene expression
- dendritic cells
- drug induced
- patient reported outcomes
- genome wide association
- binding protein
- affordable care act
- immune response
- contrast enhanced